Navigation Links
Burroughs Wellcome Fund grants $9.75 million towards translational researchers
Date:3/7/2008

RESEARCH TRIANGLE PARK, N.C. BWF has named 13 translational researchers as the 2008 recipients of its Clinical Scientist Awards in Translational Research. The awards, which provide $150,000 per year over five years ($750,000), are intended to support established, independent physician-scientists who are dedicated to translational researchthe two-way transfer between laboratory research and patient treatmentand mentoring physician-scientist trainees.

The award provides the freedom and flexibility to explore scientific questions, apply the resulting knowledge at the bedside, and bring insights from the clinical setting back to the laboratory for further study.

The Clinical Scientist Awards in Translational Research is in its tenth cycle. The award is highly competitive with an average award rate of 9 percent. In the 2008 cycle, there were 119 eligible applications. Candidates must have an M.D. or M.D.-Ph.D. degree and hold an appointment or joint appointment in a subspecialty of clinical medicine. They must also be citizens or permanent residents of the U.S. and Canada and hold a current license to practice medicine in the U.S. or Canada.

We hope these awards will lead to better understanding of the mechanisms of disease as well as new methods of diagnosing, treating and preventing disease, said BWF President Enriqueta C. Bond, Ph.D. BWF is particularly interested in supporting physician-scientists who bring novel ideas and new approaches to translational research.

Since the awards inception in 1997, BWF has made a total of 93 awardsan investment of nearly $70 million in the careers of translational researchers.

Following are the 2008 award recipients, along with their institutions and project titles:

Mark S. Anderson, M.D., Ph.D.
University of California-San Francisco
Translating aire-control of immune tolerance to human autoimmunity

Kathleen L. Collins, M.D., Ph.D.
University of Michigan-Ann Arbor
Viral mechanisms of persistence in HIV infected people

Laurence Cooper, M.D., Ph.D.
University of Texas M.D. Anderson Cancer Center
Tumor-specific alloantigen-anergic donor-derived T-cell therapy after hematopoietic stem cell transplantation

William M. Grady, M.D.
University of Washington
Novel biomarkers for the prevention and treatment of colon cancer

S. Ananth Karumanchi, M.D.
Harvard Medical School
Soluble endoglin in the pathogenesis and prediction of preclampsia

Frances Lee, M.D., Ph.D.
Weill Medical College of Cornell University
Role of BDNF in therapeutic strategies for affective disorders

Ernst R. Lengyel, M.D., Ph.D.
University of Chicago
Development of novel therapeutic and diagnostic strategies for ovarian cancer

Daniel L. Marks, M.D., Ph.D.
Oregon Health and Science University
Maternal nutrition and fetal metabolic programming

Jonathan R. Pollack, M.D., Ph.D.
Stanford University
Pathogenesis and diagnosis of clinically-indolent prostate cancer

Theodora S. Ross, M.D., Ph.D.
University of Michigan-Ann Arbor
Abnormal HIP1 and cancer biology

Jeffrey A. Toretsky, M.D.
Georgetown University Lombardi Comprehensive Cancer Center
Novel cancer therapeutics based upon oncogenic fusion-protein transcription factors

Edus H. Warren, M.D., Ph.D.
University of Washington
Toward immune therapy for colon cancer: identification of antigens recognized by CD8+ T lymphocytes on colon cancer stem cells

Kang Zhang, M.D., Ph.D.
University of Utah
Define novel genes for diabetic microvascular complications


'/>"/>

Contact: Russ Campbell
news@bwfund.org
919-991-5119
Burroughs Wellcome Fund
Source:Eurekalert

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has issued an important reminder ... at their worksites. Employers with workers exposed to high temperatures should establish ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: